Cytokinetics

Head of Investor Relations

South San Francisco, California, USA · Director

Sponsorship not specified$269k-$314kDetected 62 days ago

ComplianceAccountingResearchLeadershipCommunication

About the role

The ideal candidate is equally comfortable shaping narrative at the Board level and preparing detailed materials for earnings calls and investor conferences.
The base pay actually offered will take into account internal equity and also may vary depending on the candidate's geographic region, job-related knowledge, skills, and experience among other factors.
Our employees come from different backgrounds, and we celebrate those differences.

Develop and execute a comprehensive investor relations strategy aligned with corporate objectives and key value inflection points.
Closely collaborate with Senior Director, Corporate Communications to shape and refine Cytokinetics' narrative to ensure clarity, differentiation, and consistency across all investor and other communications.
Partner cross-functionally to anticipate and communicate major milestones, including clinical, regulatory, and commercial developments.
Lead engagement with buy-side and sell-side analysts, institutional investors, and key stakeholders. Build and cultivate strong relationships with current and potential new investors
Develop and draft briefing materials, Q&A documents, key messaging, and investor presentations.
Collaborate with Finance to monitor analyst models, reports, and shareholder base trends
Collaborate with Finance to monitor analyst models, reports, and shareholder base trends; provide actionable insights to executive leadership; engage with analysts to inform consensus.
Partner with Finance and Legal to ensure compliance with disclosure regulations and best practices.
Lead engagement with buy-side and sell-side analysts, institutional investors, and key stakeholders.
Build and cultivate strong relationships with current and potential new investors

Significant investor relations experience within the pharmaceutical or biotechnology industry is required, preferably in a publicly traded, commercial-stage company.
Strong understanding of financial and investor markets, accounting principles and regulatory requirements.
Strong understanding of drug development, regulatory pathways, clinical data interpretation, and commercial dynamics in biotech/pharma.
Exceptional written and verbal communication skills with the ability to translate complex scientific and financial information into compelling narratives.
Proven ability to operate strategically while also executing tactically and independently.
Results-oriented with proven track record for meeting or exceeding goals
Bachelor's degree required in Finance, Accounting, Communications; and/or advanced degree preferred.
12+ years of experience in investor relations, equity research, investment banking, or related capital markets roles.
Demonstrated experience working closely with C-suite executives and senior stakeholders.
Proven ability to maintain confidentiality, exercise judgment and discretion
High executive presence, sound judgment, and discretion.
Willingness to travel
#LI-HYBRID

In the U.S., the hiring pay range for fully qualified candidates is $269,100-$313,950 per year.
The base pay actually offered will take into account internal equity and also may vary depending on the candidate's geographic region, job-related knowledge, skills, and experience among other factors.

This listing is sourced directly from Cytokinetics's careers page and normalized into a canonical job model.